exist Medical City Investment, our annual conference scheduled for March 28-30 at the Ritz-Carlton, Chicago, where startups will once again take center stage in our startup pitch competition, Pitch Perfect. This year’s competition will include four tracks: Care Coordination and Value-Based Care; Remote Patient Monitoring and Smart Devices; Diagnostics 2.0 and Pharma Technology.
Finalists for the pharmatech track have been selected. They include digital therapeutic applications for gastrointestinal diseases, digital tools for breast cancer patients, improved doctor-patient communication, and more.
They will ask questions to a group of investors, who will then ask them questions and evaluate them against criteria:
- Integrity of the master plan
- Business philosophy
- Market opportunities
- income model
- Founder’s experience
The track’s judges include:
- Jessica Federer, Partner, Boston Millennium Partners
- Jeff Weness, Head of Digital Opportunity and Business Intelligence, Otsuka Pharmaceuticals (US)
- Blake Wu, Partner at NEA
To view the agenda, Click here.
So who made the short list?
Athelo Health is a biomarker-based virtual counseling platform for breast cancer patients. By providing real-time guidance for patient and healthcare navigation, Athelo improves outcomes while reducing the cost of care. Athelo serves patients throughout their treatment, providing ongoing behavioral guidance based on biometrics, including heart rate variability, blood oxygen levels, activity, and temperature. While current solutions are often indication-agnostic, Athelo is purpose-built for breast cancer patients and built on the latest medical research. The team was founded by industry experts with more than 30 years of clinical development, business strategy and engineering expertise.
Meta Health Development of FDA-approved prescription digital therapeutics for the treatment of gastrointestinal disorders. A Prescription Digital Therapy (PDT) is a software application that provides patients with evidence-based therapeutic interventions to prevent or treat a medical condition or disease. PDTs are developed under the same stringent conditions as drugs, are designed to be used like drugs, complete clinical trials, FDA approval, and can only be used with a doctor’s prescription. The lead product is Regulora®, the first FDA-authorized treatment of any type specifically for irritable bowel syndrome (IBS)-related abdominal pain in adults. Regulora® is a prescription digital therapy that is self-administered from an Apple or Android smartphone. Abdominal pain is the predominant symptom of all IBS subtypes and the number one reason patients seek IBS treatment.
OneFul is the only source of personalized combination therapies, manufactured with high quality using advanced automation technology, with many combinations priced as low as $1.00 per day. Through an electronic pharmacy portal, OneFul can receive prescriptions from doctors or connect patients with qualified doctors in their network, using the latest tools to dispense the right medication in the right dose.
sensory health Founded in Chapel Hill, North Carolina by a team of pharmacists, it helps patients cope with challenging and often debilitating skin conditions. It is piloting the world’s only platform dedicated to monitoring patient adherence to dermatological drug treatments, including topical and oral dosage forms. Its solutions include a suite of patented electronic monitoring devices, apps and analytics that provide unparalleled insight into patient adherence to medication. Clients we serve include pharmaceutical manufacturers, clinical trial facilities, clinicians and pharmacy systems. A team of seasoned pharmacists, tech entrepreneurs and behavioral health/data science experts has a tight network of technology partners. Its advisors are superstars in their fields. After three years, we will launch pilots with major pharmaceutical brands to expand their technology pipelines and validate assays. The next phase will continue the commercialization momentum of the stable phase to achieve its vision.
tell health An online community is being created to bring doctors and patients closer together. The goal is to allow for freer communication, better record keeping and a sense of empowerment. Tell Health is a purely medical space for therapists and their patients to share information. Bring patients and health professionals closer together. The company helps foster a deeper relationship between patients and physicians by creating a sense of connection we could not have imagined just a few years ago.
Photo: Adrian Hillman, Getty Images
